UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist

PloS one, 2012-11, Vol.7 (11), p.e49572

2012

Volltextzugriff (PDF)

Effects of Peripherally Administered Neuromedin U on Energy and Glucose Homeostasis

Endocrinology (Philadelphia), 2011-07, Vol.152 (7), p.2644-2654

2011

Volltextzugriff (PDF)

Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension

Journal of the American Society of Hypertension, 2011-05, Vol.5 (3), p.166-176

2011

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs

Molecular pharmacology, 2011-12, Vol.80 (6), p.1156-1165

2011

Volltextzugriff (PDF)

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase‐4 inhibition following single doses of sitagliptin in healthy, young Japanese males

British journal of clinical pharmacology, 2011-03, Vol.71 (3), p.429-436

2011

Volltextzugriff (PDF)

Montelukast in the treatment of allergic rhinitis : An evidence-based review

Drugs (New York, N.Y.), 2007-01, Vol.67 (6), p.887-901

2007

Volltextzugriff (PDF)

Single-Dose Montelukast or Salmeterol as Protection Against Exercise-Induced Bronchoconstriction

Chest, 2007-09, Vol.132 (3), p.875-883

2007

Volltextzugriff (PDF)

A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat

European journal of pharmacology, 2010-08, Vol.640 (1), p.250-256

2010

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Current medical research and opinion, 2008-02, Vol.24 (2), p.537-550

2008

Volltextzugriff (PDF)

A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors

Clinical cancer research, 2011-10, Vol.17 (19), p.6304-6312

2011

Volltextzugriff (PDF)

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Current medical research and opinion, 2011-05, Vol.27 (5), p.1049-1058

2011

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea

Diabetes research and clinical practice, 2009-01, Vol.83 (1), p.106-116

2009

Volltextzugriff (PDF)

A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure

International journal of cardiology, 2018-01, Vol.250, p.215-222

2018

Volltextzugriff (PDF)

Erratum to “A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure” [Int. J. Cardiol. 250 (2018) 215–222]

International journal of cardiology, 2018-03, Vol.254, p.368-371

2018

Volltextzugriff (PDF)

Deficient Neurogenesis in Forebrain-Specific Presenilin-1 Knockout Mice Is Associated with Reduced Clearance of Hippocampal Memory Traces

Neuron (Cambridge, Mass.), 2001-12, Vol.32 (5), p.911-926

2001

Volltextzugriff (PDF)

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30 days with MK-7123, a selective CXCR2 antagonist

International immunopharmacology, 2013-10, Vol.17 (2), p.178-183

2013

Volltextzugriff (PDF)

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects

International journal of clinical pharmacology and therapeutics, 2014-03, Vol.52 (3), p.227-236

2014

Volltextzugriff (PDF)

Disruption of retinogeniculate afferent segregation by antagonists to NMDA receptors

Nature (London), 1991-06, Vol.351 (6327), p.568-570

1991

Volltextzugriff (PDF)

Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment

European journal of clinical pharmacology, 2012-11, Vol.68 (11), p.1501-1508

2012

Volltextzugriff (PDF)

Pharmacokinetic–pharmacodynamic studies of the 11β‐hydroxysteroid dehydrogenase type 1 inhibitor MK‐0916 in healthy subjects

British journal of clinical pharmacology, 2013-12, Vol.76 (6), p.917-931

2013

Volltextzugriff (PDF)

Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin

Diabetes therapy, 2013-12, Vol.4 (2), p.431-442

2013

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

European journal of clinical pharmacology, 2012-07, Vol.68 (7), p.1049-1056

2012

Volltextzugriff (PDF)

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

International journal of clinical pharmacology and therapeutics, 2014-08, Vol.52 (8), p.631-641

2014

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes (一项为期54周的对持续使用二甲双胍与罗格列酮联合治疗的2型糖尿病患者加用西格列汀治疗的有效性与安全性的随机安慰剂对照研究)

Journal of diabetes, 2013-03, Vol.5 (1), p.68-79

2013

Volltextzugriff (PDF)

A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

Cancer medicine (Malden, MA), 2014-08, Vol.3 (4), p.988-997

2014

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(36)
Male
(26)
Humans
(25)
Biological And Medical Sciences
(21)
Female
(20)
Adult
(19)
Middle Aged
(19)
Aged
(16)
Animals
(16)
Medical Sciences
(15)
Pharmacology. Drug Treatments
(13)
Pharmacology & Pharmacy
(12)
Neurosciences
(8)
Neurosciences & Neurology
(8)
Dose-Response Relationship, Drug
(7)
Double-Blind Method
(7)
Oncology
(7)
Antineoplastic Agents
(6)
Diabetes Mellitus, Type 2 - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist

Effects of Peripherally Administered Neuromedin U on Energy and Glucose Homeostasis

Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension

Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase‐4 inhibition following single doses of sitagliptin in healthy, young Japanese males

Montelukast in the treatment of allergic rhinitis : An evidence-based review

Single-Dose Montelukast or Salmeterol as Protection Against Exercise-Induced Bronchoconstriction

A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea

A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure

Erratum to “A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure” [Int. J. Cardiol. 250 (2018) 215–222]

Deficient Neurogenesis in Forebrain-Specific Presenilin-1 Knockout Mice Is Associated with Reduced Clearance of Hippocampal Memory Traces

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30 days with MK-7123, a selective CXCR2 antagonist

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects

Disruption of retinogeniculate afferent segregation by antagonists to NMDA receptors

Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment

Pharmacokinetic–pharmacodynamic studies of the 11β‐hydroxysteroid dehydrogenase type 1 inhibitor MK‐0916 in healthy subjects

Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

Suchergebnisse filtern